← FDA Drug Approvals (Drugs@FDA)

HYDRALAZINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PARENTERAL · Approved 2000-02-23

Drug application

FDA Application #

ANDA040373

Application type

Abbreviated New Drug Application (Generic)

Brand name

HYDRALAZINE HYDROCHLORIDE

Generic name

Hydralazine Hydrochloride

Active ingredients

HYDRALAZINE HYDROCHLORIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

TEVA PARENTERAL

First approval

2000-02-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown